Orbimed Advisors - PROTARA THERAPEUTICS INC ownership

PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 31 filers reported holding PROTARA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of PROTARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,290,215
-30.1%
772,5840.0%0.03%
-18.2%
Q2 2023$1,846,476
-25.7%
772,584
-2.6%
0.03%
-32.7%
Q1 2023$2,483,837
+11.6%
793,558
-4.5%
0.05%
+14.0%
Q4 2022$2,226,118
-9.5%
830,6410.0%0.04%
-6.5%
Q3 2022$2,459,000
+1.0%
830,6410.0%0.05%
+4.5%
Q2 2022$2,434,000
-42.7%
830,6410.0%0.04%
-36.2%
Q1 2022$4,245,000
-24.3%
830,6410.0%0.07%
-4.2%
Q4 2021$5,607,000
+80.1%
830,641
+84.6%
0.07%
+111.8%
Q3 2021$3,114,000
-29.0%
450,0000.0%0.03%
-22.7%
Q2 2021$4,383,000
-38.1%
450,0000.0%0.04%
-33.3%
Q1 2021$7,083,000
-35.0%
450,0000.0%0.07%
-30.5%
Q4 2020$10,895,000
+43.8%
450,0000.0%0.10%0.0%
Q3 2020$7,574,000450,0000.10%
Other shareholders
PROTARA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,692,594$4,496,6321.46%
Privium Fund Management (UK) Ltd 119,730$201,1460.16%
Ikarian Capital, LLC 188,664$315,0690.04%
Orbimed Advisors 772,584$1,290,2150.03%
Boxer Capital, LLC 209,227$349,4090.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 64,000$106,8800.00%
Baker Brothers Advisors 199,671$333,4510.00%
BOOTHBAY FUND MANAGEMENT, LLC 18,864$31,5030.00%
TWO SIGMA INVESTMENTS, LP 27,345$45,6660.00%
OSAIC HOLDINGS, INC. 100$1670.00%
View complete list of PROTARA THERAPEUTICS INC shareholders